ArticleSignal transduction and targeted therapy2026

Exogenous Epstein-Barr virus nuclear antigen 1 induces ADAR1-driven tumor resistance against immunotherapy.

Changlin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.